Authors




Alexander J. Mainor, JD

Latest:

Overuse and Insurance Plan Type in a Privately Insured Population

Health insurance plan type may be an important lever for reducing low-value healthcare use among patients with commercial insurance.


Beth Barber, PhD

Latest:

Characterizing Medical Care by Disease Phase in Metastatic Colorectal Cancer

This study characterized patterns and costs of medical care by disease phase in patients with newly diagnosed mCRC using a large US national commercially insured claims database.


Surya Singh, MD

Latest:

Managing Costs and Enhancing the Value of Oncology Care

Management of high and rising costs in oncology requires a multifaceted approach using both innovative strategies and pragmatic tools. In this article, we discuss several factors that influence the costs of oncology care.



Richard Brand, PhD

Latest:

Inpatient-Outpatient Shared Electronic Health Records: Telemedicine and Laboratory Follow-up After Hospital Discharge

Using a seamlessly shared inpatient-outpatient electronic health record was associated with greater rates of postdischarge follow-up delivered through telemedicine or laboratory monitoring and without an in-person office visit.


James Hu, MD, FACP

Latest:

Bridging the Care Gap Between Pediatric and Young Adult Cancer

Through a multi-site, multidisciplinary approach, AYA@USC addresses the unique needs of young adult cancer patients, improving outcomes and bridging the care gap in this population.


managed care, healthcare, American Journal of Managed Care, hypertension, diabetes, cardiovascular, treatment, financial pressure, medication, copayment, Medicare, Medicaid, Affordable Care Act, value

Latest:

AJMC Study Confirms Link Between Financial Stress, Failure to Stick With Hypertension Medication

A new study adds to the evidence that financial pressure, or the perception of pressure, may keep patients from getting treatment or taking medication for chronic conditions such as hypertension.


Wallace Stephens

Latest:

Research Report: ASCO 2019

Selected abstracts from the 2019 Annual Meeting of the American Society of Clinical Oncology.


Satyin Kaura, MSci, MBA

Latest:

The Value of Survival Gains in Myelodysplastic Syndromes

This study measured the value of survival gains attributable to the introduction of 3 novel therapies for myelodysplastic syndromes.




Soeren Mattke, MD, DSc

Latest:

Concluding Remarks: Impact of Alzheimer Disease, Promising Treatments in Development, and Future Outlook

Looking to the future of Alzheimer disease treatment, the panel discusses key takeaways on the evolving therapeutic landscape.


Geoffrey F. Joyce, PhD

Latest:

Did Medicare Part D Reduce Disparities?

This study examined the impact of the Medicare Part D coverage gap on medication use by Hispanics, blacks, and whites with diabetes.


Krissy K. Moehling, MPH

Latest:

Using the 4 Pillars to Increase Vaccination Among High-Risk Adults: Who Benefits?

Pneumococcal; tetanus, diphtheria, and pertussis; and influenza vaccination increased among high-risk adults in a 2-year study.






Gabrielle Gundersen, MPH

Latest:

Primary Care Physician Resource Use Changes Associated With Feedback Reports

Implementing systemwide dissemination of feedback reports to primary care physicians in an integrated delivery system may be associated with changes in medical resource use.


Michaela A. Dinan, PhD

Latest:

Trends in Hospital–Physician Integration in Medical Oncology

The authors used Medicare claims data to examine trends in hospital–physician integration in high-volume specialties, including medical oncology.


Carolina dos Santos, BA

Latest:

Improvement of Outpatient Quality Metrics in a Limited-Resource Setting

This study presents an example of a population health initiative in a limited-resource primary care setting that led to significant improvements in preventive care quality metrics in the context of major insurance payers.


Seema S. Sonnad, PhD

Latest:

True "Meaningful Use": Technology Meets Both Patient and Provider Needs

A qualitative study of patient and provider perspectives regarding the after-visit summary and the patient portal features of the electronic health record.




Dawn I. Velligan, PhD

Latest:

Adalimumab Persistence for Inflammatory Bowel Disease in Veteran and Insured Cohorts

Veterans with inflammatory bowel disease taking adalimumab appear to be more likely to remain on the drug 1 year after initiation than patients who are privately insured.


Frederic C. Blow, PhD

Latest:

Depression Care Following Psychiatric Hospitalization in the Veterans Health Administration

Different patient characteristics predict adequate antidepressant treatment after hospitalization, received by 58.7% of patients, versus adequate psychotherapy, received by 12.9% of patients.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo